Related Experiment Video
Updated: Jul 18, 2026
09:52
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Allergic bronchopulmonary aspergillosis: a US perspective
Christine Virnig1, Robert K Bush
1William S. Middleton VA Hospital, Madison, Wisconsin 53705, USA.
Current Opinion in Pulmonary Medicine
|November 30, 2006
Summary
Allergic bronchopulmonary aspergillosis (ABPA) affects asthma and cystic fibrosis patients. New research into its genetics, pathophysiology, and diagnostics promises improved patient treatment.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Infectious Diseases
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) is a rare pulmonary disease.
- It primarily affects individuals with asthma and cystic fibrosis.
- Early diagnosis and management are crucial for better patient outcomes.
Purpose of the Study:
- To provide an update on the current understanding of allergic bronchopulmonary aspergillosis.
- To highlight recent advancements in research concerning ABPA.
- To emphasize the importance of prompt recognition and treatment.
Main Methods:
- Review of current literature and research findings on ABPA.
- Analysis of emerging insights into the pathophysiology and genetics of ABPA.
- Evaluation of ongoing research into novel diagnostic techniques, including recombinant Aspergillus allergens.
Main Results:
- Active research is yielding significant insights into ABPA pathophysiology and genetics.
- Development of recombinant Aspergillus allergens shows promise for improved diagnosis.
- Current research efforts are focused on understanding the disease mechanisms and improving diagnostic accuracy.
Conclusions:
- New understanding of ABPA genetics and pathophysiology can enhance patient treatment.
- Novel diagnostic techniques, aided by recombinant allergens, offer potential for earlier detection.
- Continued research in these areas is vital for advancing the management of ABPA.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...